Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(02): 193-195
DOI: 10.4103/ijmpo.ijmpo_100_17
Original Article

Effect of Ethanol as an Adjuvant to Extended Curettage on Recurrence Rate of Unicameral Bone Cyst

Saeed Solooki
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
,
Hamideh Mahdaviazad
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
,
Amir Reza Vosoughi
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
,
Yaghoob Keikha
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
,
Babak Pourabbas
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
,
Seyed Ali Hashemi
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Chamran Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
› Author Affiliations

Financial support and sponsorship Nil.
Preview

Abstract

Background: To assess the efficacy of ethanol as an adjuvant in the treatment of unicameral bone cyst (UBC). Materials and Methods: Surgically treated patients with UBC lesion were reviewed. Definite treatment of UBC lesions was conducted using a combined four-step alcohol-using approach, consisted of curettage, burring, ethanol 96%, and electrocauterization of the lesion, consecutively. Results: Twenty-one patients (mean age 14, range: 2–30, male 62%) were followed from 1 to 10 years. Among 18 cases, only one recurrence was seen in a 5-year-old boy with UBC of the left calcaneus. Conclusions: Using ethanol as an adjuvant may be a good choice for treatment of UBC lesions.



Publication History

Article published online:
23 June 2021

© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India